Clinical Trials Logo

Filter by:
NCT ID: NCT01947127 Completed - Sepsis Clinical Trials

Venous Lactate in Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients in Emergency Department

Start date: March 2013
Phase: N/A
Study type: Observational [Patient Registry]

To investigate the role of initial venous lactate in predicting the severity progression to overt septic shock and 30-day mortality in non-elderly patients without hemodynamic shock who suspected to have acute infections.

NCT ID: NCT01945983 Completed - Septic Shock Clinical Trials

Early Use of Norepinephrine in Septic Shock Resuscitation

CENSER
Start date: October 3, 2013
Phase: N/A
Study type: Interventional

Current septic shock guideline recommends fluid resuscitation as the first treatment. Vasopressors, including norepinephrine is recommended to start after achieve adequate fluid therapy. This can cause a certain duration of systemic hypotension before vasopressor is commenced. Initiation of norepinephrine together with fluid therapy soon after diagnosis of septic shock may increase blood pressure quicker than start treatment with intravenous fluid alone. The rapid restoration of perfusion pressure may improve septic shock outcome.

NCT ID: NCT01944176 Completed - COPD Clinical Trials

The Effects of Simvastatin on Th17 Cytokines and Th17 Polarizing Cytokine in COPD Patients

Start date: September 2013
Phase: Phase 3
Study type: Interventional

Airway inflammation is partly driven by Th17 and Th17-polarizing cytokines that is steroid-resistant. Statins could suppress IL-17 cytokines in other diseases such as atherosclerosis and multiple sclerosis in mouse model. The investigators hypothesize that statins might provide anti-inflammatory benefit of suppressing IL-17 cytokines in COPD patients.

NCT ID: NCT01943032 Completed - Clinical trials for Malignant Neoplasm of Breast.

Discordant Hormonal Status of Breast Cancer.

Start date: April 2011
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study is to determine discordant hormonal status of primary breast tumor and metastatic breast cancer cells at regional lymph nodes in node positive breast cancer patients.

NCT ID: NCT01943006 Completed - Phlebitis Clinical Trials

Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis

Start date: May 2015
Phase: Phase 3
Study type: Interventional

Patients receiving nutritional emulsion for at least 3 days will be treated with Hirudoid cream or placebo cream to prevent and treat phlebitis caused by the infusion. The treatment is continued after the end of infusion for at least 7 days. Number of patients developing superficial phlebitis and duration of phlebitis will be recorded.

NCT ID: NCT01942421 Active, not recruiting - Clinical trials for Ocular Surface Disease

Ocular Surface Reconstruction With Cultivated Autologus Mucosal Epithelial Transplantation

Start date: January 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to elucidate the appropriate condition of developing cultivated autologous oral mucosal epithelial graft and evaluate the surgical outcome of transplantation of the cultivated cells in the patients.

NCT ID: NCT01939093 Completed - Clinical trials for Methamphetamine-induced Psychosis

Therapeutic Effect of Quetiapine on Methamphetamine-Induced Psychosis

MAP
Start date: March 2010
Phase: Phase 4
Study type: Interventional

The aims of this study are to compare the antipsychotic and adverse events of quetiapine, an atypical antipsychotic drug, to haloperidol, a standard treatment for primary psychotic disorder, in individuals with MAP.

NCT ID: NCT01935739 Completed - Clinical trials for Malignant Neoplasm of Breast.

Discordant HER2/Neu Status of Breast Cancer.

Start date: June 2010
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study is to determine discordant HER2/neu status of primary breast tumor and metastatic breast cancer cells at regional lymph nodes in node positive breast cancer patients.

NCT ID: NCT01933945 Completed - Clinical trials for Carcinoma, Hepatocellular

Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib

OPTIMIS
Start date: October 28, 2013
Phase:
Study type: Observational

This study will collect data of patients who are treated with TACE followed by sorafenib for hepatocellular carcinoma (HCC) or patients without Sorafenib after TACE. In contrast to a prior observational study on sorafenib (GIDEON study), where pre-treatment with TACE was documented retrospectively, this study will collect more detailed information about the TACE treatment and the status of a patient when treatment with sorafenib is started.

NCT ID: NCT01933685 Active, not recruiting - HIV Infections Clinical Trials

Study of Immune Responses Induced by a HIV Vaccine

Start date: July 3, 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to define the immune responses induced by a HIV vaccine, AIDSVAX B/E. Blood and mucosal samples will be collected to assess immune responses.